Home › Cervical Cancer › Ohio › Columbus
Cervical Cancer clinical trials in Columbus, OH
12 studies for Cervical Cancer are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RecruitingPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6002), Columbus
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- Ohio Health Arthur G.H. Bing - MD Cancer Center, Columbus
- OhioHealth Research Institute, Columbus
- Riverside Methodist Hospital, Columbus
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RecruitingPhase 2
- Research Site, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Recruiting
- OSU Wexner Medical Center Hospital East, Columbus
- OSU Wexner Medical Center Outpatient Care East, Columbus
- James Cancer Hospital & Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
- and 9 more
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
The Ohio State University (OSU) SCREEN Community Program
RecruitingHealthy volunteers welcome
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecruitingPhase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Columbus
About Cervical Cancer
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
More about Cervical Cancer on MedlinePlus
Cervical Cancer trials in other cities
- Houston, TX34 studies
- New York City, NY20 studies
- Nashville, TN19 studies
- Boston, MA19 studies
- Arlington, VA18 studies
- Los Angeles, CA17 studies
- San Antonio, TX14 studies
- Dallas, TX14 studies
- St. Louis, MO12 studies
- Orlando, FL12 studies
- Baldwin Park, CA11 studies
- San Diego, CA11 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer57 studies
- Cancer (all types)40 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer25 studies
- Multiple Myeloma25 studies
- Prostate Cancer25 studies
- Endometrial Cancer24 studies
- Colorectal Cancer24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.